168 related articles for article (PubMed ID: 36382792)
21. Effective Oxidation-Responsive Polyester Nanocarriers for Anti-Inflammatory Drug Delivery.
He P; Tang B; Li Y; Zhang Y; Liu X; Guo X; Wang D; She P; Xiao C
Int J Nanomedicine; 2021; 16():5053-5064. PubMed ID: 34349508
[TBL] [Abstract][Full Text] [Related]
22. Enhanced efficiency of mitochondria-targeted peptide SS-31 for acute kidney injury by pH-responsive and AKI-kidney targeted nanopolyplexes.
Liu D; Jin F; Shu G; Xu X; Qi J; Kang X; Yu H; Lu K; Jiang S; Han F; You J; Du Y; Ji J
Biomaterials; 2019 Aug; 211():57-67. PubMed ID: 31085359
[TBL] [Abstract][Full Text] [Related]
23. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.
Doggui S; Sahni JK; Arseneault M; Dao L; Ramassamy C
J Alzheimers Dis; 2012; 30(2):377-92. PubMed ID: 22426019
[TBL] [Abstract][Full Text] [Related]
24. Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells.
Chang PY; Peng SF; Lee CY; Lu CC; Tsai SC; Shieh TM; Wu TS; Tu MG; Chen MY; Yang JS
Int J Oncol; 2013 Oct; 43(4):1141-50. PubMed ID: 23917396
[TBL] [Abstract][Full Text] [Related]
25. Fucoidan-ferulic acid nanoparticles alleviate cisplatin-induced acute kidney injury by inhibiting the cGAS-STING pathway.
Gao X; Wang J; Wang Y; Liu S; Dong K; Wu J; Wu X; Shi D; Wang F; Guo C
Int J Biol Macromol; 2022 Dec; 223(Pt A):1083-1093. PubMed ID: 36372101
[TBL] [Abstract][Full Text] [Related]
26. Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment.
Cheng YH; Ko YC; Chang YF; Huang SH; Liu CJ
Exp Eye Res; 2019 Feb; 179():179-187. PubMed ID: 30471279
[TBL] [Abstract][Full Text] [Related]
27. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model.
Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G
Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445
[TBL] [Abstract][Full Text] [Related]
28. Role of curcumin in the treatment of acute kidney injury: research challenges and opportunities.
Cai Y; Huang C; Zhou M; Xu S; Xie Y; Gao S; Yang Y; Deng Z; Zhang L; Shu J; Yan T; Wan CC
Phytomedicine; 2022 Sep; 104():154306. PubMed ID: 35809376
[TBL] [Abstract][Full Text] [Related]
29. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
[TBL] [Abstract][Full Text] [Related]
30. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.
Hong Y; Che S; Hui B; Wang X; Zhang X; Ma H
Drug Des Devel Ther; 2020; 14():2263-2274. PubMed ID: 32606596
[TBL] [Abstract][Full Text] [Related]
31. Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling.
Al Fayi M; Otifi H; Alshyarba M; Dera AA; Rajagopalan P
J Drug Target; 2020 Nov; 28(9):913-922. PubMed ID: 31983246
[TBL] [Abstract][Full Text] [Related]
32. Relief of oxidative stress and cardiomyocyte apoptosis by using curcumin nanoparticles.
Li J; Zhou Y; Zhang W; Bao C; Xie Z
Colloids Surf B Biointerfaces; 2017 May; 153():174-182. PubMed ID: 28237821
[TBL] [Abstract][Full Text] [Related]
33. Silibinin ameliorates cisplatin-induced acute kidney injury via activating Nfe2l1-mediated antioxidative response to suppress the ROS/MAPK signaling pathway.
Yang F; Jia M; Deng C; Xiao B; Dai R; Xiang Y
J Mol Histol; 2022 Aug; 53(4):729-740. PubMed ID: 35727472
[TBL] [Abstract][Full Text] [Related]
34. A multifunctional CeO
Chen Z; Xu L; Gao X; Wang C; Li R; Xu J; Zhang M; Panichayupakaranant P; Chen H
Food Res Int; 2020 Nov; 137():109674. PubMed ID: 33233251
[TBL] [Abstract][Full Text] [Related]
35. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous Elimination of Reactive Oxygen Species and Activation of Nrf2 by Ultrasmall Nanoparticles to Relieve Acute Kidney Injury.
Bao B; Liu H; Han Y; Xu L; Xing W; Li Z
ACS Appl Mater Interfaces; 2023 Apr; 15(13):16460-16470. PubMed ID: 36946292
[TBL] [Abstract][Full Text] [Related]
37. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.
Zhao X; Chen Q; Liu W; Li Y; Tang H; Liu X; Yang X
Int J Nanomedicine; 2015; 10():257-70. PubMed ID: 25565818
[TBL] [Abstract][Full Text] [Related]
38. Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway.
Yang SK; Han YC; He JR; Yang M; Zhang W; Zhan M; Li AM; Li L; Na-Song ; Liu YT; Wu XQ; Zhang Q; Wang JW; Zhang H
Biomed Pharmacother; 2020 Oct; 130():110521. PubMed ID: 32717631
[TBL] [Abstract][Full Text] [Related]
39. Graft copolymer nanoparticles with pH and reduction dual-induced disassemblable property for enhanced intracellular curcumin release.
Zhao J; Liu J; Xu S; Zhou J; Han S; Deng L; Zhang J; Liu J; Meng A; Dong A
ACS Appl Mater Interfaces; 2013 Dec; 5(24):13216-26. PubMed ID: 24313273
[TBL] [Abstract][Full Text] [Related]
40. An E-selectin targeting and MMP-2-responsive dextran-curcumin polymeric prodrug for targeted therapy of acute kidney injury.
Hu JB; Liu D; Qi J; Lu KJ; Jin FY; Ying XY; You J; Du YZ
Biomater Sci; 2018 Nov; 6(12):3397-3409. PubMed ID: 30371703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
